NB-0893
N/A
Report date: 2022/10/10 16:53:16
Base Information
Drug NameNB-0893
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toronto, TorontoUniversity Health Network (Uhn)Northern Biologics Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNorthern Biologics IncC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A